Eli Lilly and Company CEO Forecasts Drug Maker’s Evolution

INDIANAPOLIS (AP) — Eli Lilly and Co. aims to grow leaner and more diverse as it pushes to keep pace with changes spreading through the drug industry, CEO John Lechleiter said in a Wednesday afternoon speech.